Neurocrine Biosciences, Inc. To Present At The 24th Annual JP Morgan Healthcare Conference

SAN DIEGO, Jan. 9 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will present at the 24th Annual JP Morgan Healthcare Conference Wednesday, January 11 at 3:00 PM Pacific Time (PT) / 6:00 PM Eastern Time (ET) at the Westin St. Francis in San Francisco. The presentation will be simultaneously webcast and can be accessed on the Company’s website.

Gary Lyons, President and Chief Executive Officer of Neurocrine will present a Company overview that will include an update on Neurocrine’s broad development pipeline and research programs and indiplon highlights.

To view the webcast, log on to the Company’s website at http://www.neurocrine.com approximately five minutes prior to the presentation. Select the “Click here to access the JPMorgan Webcast” link, then under “Webcasts” select “24th Annual JPMorgan Healthcare Conference” and follow instructions for registration. Upon registering, the conference “Welcome Page” will appear. Click on the “Live Webcast” link to the left and then click on “Neurocrine.” A replay of the presentation will become available approximately 24 hours after the live event concludes and will be archived until Wednesday, January 25, 2006.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com.

Neurocrine Biosciences, Inc.

CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, Inc., +1-858-617-7600

MORE ON THIS TOPIC